4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-108964
President/CEO bought 250 shares at $2.90 ($725)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President/CEO | 2024-10-15 | Purchase | +250 | $2.90 | $725 | 332,895 | D |
| Open-market purchases · 250 sh · avg $2.90 · $725 | |||||||
Loading xslF345X05/tm2426059-6_4seq1.xml…